| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |